Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
There is much we can restore
News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s
Clinical studies have also examined its role in supporting healthy inflammatory responses in respiratory tissues, making it a valuable addition to comprehensive lung health protocols
doi:10.1177/1076029616674825
/assets/images/provider/photos/2788220.png)
US$ 22.88
US$ 23.10
US$ 26.03
US$ 21.78
US$ 29.50
